Eric Umansky

2 days ago | alternet.org | Vernal Coleman |Eric Umansky

Democratic House members on Thursday blasted the Trump administration’s moves to shrink the Department of Veterans Affairs and demanded more transparency from its leaders after a ProPublica investigation revealed widespread disruptions across the agency’s health care system. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. “There are real-life dangerous impacts for veterans,” said Rep.

5 days ago | propublica.org | Chris Bing |Avi Asher-Schapiro |Vernal Coleman |Eric Umansky

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The ranking member of the House Oversight Committee is launching an investigation into whether the General Services Administration has given preferential treatment to a technology startup competing for a lucrative government contract. The startup is backed by some of President Donald Trump’s most influential Silicon Valley allies.

5 days ago | businessandamerica.com | Eric Umansky |Vernal Coleman

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. If you’ve experienced setbacks in your care or benefits amid the changes at the Department of Veterans Affairs, ProPublica wants to hear from you. Share your story. Earlier this year, doctors at Veterans Affairs hospitals in Pennsylvania sounded an alarm.

5 days ago | businessandamerica.com | Eric Umansky |Vernal Coleman |Maryam Jameel

As the Trump administration pledges to eliminate 80,000 employees at the U.S. Department of Veterans Affairs, ProPublica reporters are investigating how changes at the VA are affecting veterans themselves. Trump has promised to put veterans first, but our reporting shows veterans’ care is suffering amid wide-ranging cuts. If you’ve experienced setbacks in your care, we want to hear from you. We would also appreciate firsthand insights about changes happening within the VA from agency employees.

5 days ago | propublica.org | David Armstrong |Vernal Coleman |Eric Umansky |Kavitha Surana

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. In the U.S., the price of Revlimid, a brand-name cancer drug, has been increasing for two decades. It now sells for nearly $1,000 a pill. In Europe, the price has been consistently lower — in some countries by two-thirds. I started reporting on Revlimid after I was prescribed the drug following a diagnosis of multiple myeloma, an incurable blood cancer.